CLL-584 Genomic Alterations and Outcomes With Fixed-Duration Ibrutinib + Venetoclax: Results From the Phase 3 GLOW Study in Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
| Autor: | Kater, Arnon, Hodkinson, Brendan, Moreno, Carol, Munir, Talha, Levin, Mark-David, Niemann, Carsten, Qi, Keqin, Sinet, Pierre, Baeten, Kurt, Caces, Donne Bennett, Srinivasan, Srimathi |
|---|---|
| Zdroj: | In Clinical Lymphoma, Myeloma and Leukemia September 2023 23 Supplement 1:S329-S329 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect